Cell News and Research

RSS

bit.bio raises in excess of $100 million in first close of Series B financing

Today bit.bio announces the first close of their Series B financing of $103 million.

From bit.bio 6 Nov 2021

Formation of transcription factories in living cells resembles the condensation of liquids

It is essential for cells to control precisely which of the many genes of their genetic material they use. This is done in so-called transcription factories, molecular clusters in the nucleus.

5 Nov 2021

Generating Cell Repellent Surfaces in Microfluidic Devices

AMSBIO report that researchers from the Medical University of Vienna (Austria), have used Lipidure® - CM5206 to coat channels in their novel microfluidic devices, to prevent cell adhesion.

From AMS Biotechnology 5 Nov 2021

Earlier known protein complex acts as a centriole stabilizer, says study

Microtubules are fibers in cells that construct a network to offer shape and structure to cells along with mediating transport mechanisms.

4 Nov 2021

Research uncovers key component of cellular malfunction that contributes to tumor growth

Scientists have homed in on a crucial step within the sequence of chemical reactions that govern regulation of cell division, proliferation and death, and whose malfunction contributes to the growth of tumors.

3 Nov 2021

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University of California, Davis.

From The University of California, Davis 2 Nov 2021

Research reveals how foodborne infections protect the gut's nervous system

A simple stomach bug could do a lot of damage. There are 100 million neurons scattered along the gastrointestinal tract-;directly in the line of fire-;that can be stamped out by gut infections, potentially leading to long-term GI disease.

1 Nov 2021

Study reveals what causes T cells to be non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

1 Nov 2021

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world's second leading cause of blindness.

1 Nov 2021

SARS-CoV-2 virus may be able to infect the inner ear, study shows

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

1 Nov 2021

Key networks controlling pluripotency and apoptosis during development revealed

During the early stages of human embryonic development, a small collection of cells called human embryonic stem cells co-ordinates growth and differentiation finally giving rise to highly specialized human tissues.

1 Nov 2021

Study employs engineered base editors for controllable genome editing

According to a recent study, targeted mutations to the genome can be instituted by splitting specific mutator enzymes and later inducing them to reconstitute.

1 Nov 2021

Study unravels unknown facts about SARS-CoV-2 infection

Around 3%–10% of the individuals infected by the SARS-CoV-2 experience moderate to severe disease.

1 Nov 2021

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

29 Oct 2021

Researchers develop new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells. Their technology can detect specific messenger RNA sequences in cells, and that detection then triggers production of a specific protein from a transgene, or artificial gene.

From Massachusetts Institute of Technology (MIT) 29 Oct 2021

Discovery of long-lived mitochondrial proteins reveals increased stability of the electron transport chain

Mitochondria are known as the powerhouses of the cell, generating the energy that's needed to fuel the functions that our cells carry out.

29 Oct 2021

New eToeholds could make RNA therapeutics more safer and effective

RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities.

29 Oct 2021

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.

29 Oct 2021

Researchers reveal the dual function of a zinc finger protein

Human genome mapping was followed by rapid scientific advancements that showed the astonishingly complex world of genetics.

29 Oct 2021

Cancer cells change their shape and migration modes more often, says research

Recent research from the Oregon State University shows how malignant cells change their shape and migration techniques to attack various tissues.

29 Oct 2021

Cell News and Research

bit.bio raises in excess of $100 million in first close of Series B financing

Formation of transcription factories in living cells resembles the condensation of liquids

Generating Cell Repellent Surfaces in Microfluidic Devices

Earlier known protein complex acts as a centriole stabilizer, says study

Research uncovers key component of cellular malfunction that contributes to tumor growth

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Research reveals how foodborne infections protect the gut's nervous system

Study reveals what causes T cells to be non-responsive to immunotherapy

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

SARS-CoV-2 virus may be able to infect the inner ear, study shows

Key networks controlling pluripotency and apoptosis during development revealed

Study employs engineered base editors for controllable genome editing

Study unravels unknown facts about SARS-CoV-2 infection

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Researchers develop new approach to selectively turn on gene therapies in target cells

Discovery of long-lived mitochondrial proteins reveals increased stability of the electron transport chain

New eToeholds could make RNA therapeutics more safer and effective

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Researchers reveal the dual function of a zinc finger protein

Cancer cells change their shape and migration modes more often, says research

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Commercializing Innovation in a Life Sciences Ecosystem

Latest in Genomics